Woodline Partners’s Rhythm Pharmaceuticals RYTM Stock Holding History

Woodline Partners’s Portfolio RYTM Stock Details RYTM Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$58.6M	Buy
2025 Q2	$32.5M	Buy
2024 Q4	–	Sell
2024 Q3	$7.53M	Buy
2024 Q2	$1.82M	Sell
2024 Q1	$7.46M	Buy
2023 Q4	$3.44M	Buy